Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Ann Surg. 2021 Aug 1;274(2):e108–e114. doi: 10.1097/SLA.0000000000003556

TABLE 3.

Odds Ratio for Preoperative Benzodiazepine or Z-drug Prescription on Composite Outcome Adjusted for Covariates

Total N N (%) experiencing composite outcome Unadjusted OR (95% CI) Adjusted OR (95% CI)
Multivariable regression for benzodiazepine or Z-drug class
 No prescription 690,459 15,474 (2.24) Reference
 Z-drug 35,324 1180 (3.34) 1.51 (1.42–1.60) 1.18 (1.11–1.26)
 Short-/intermediate-acting benzodiazepine 49,961 1597 (3.20) 1.44 (1.37–1.52) 1.11 (1.05–1.17)
 Long-acting benzodiazepine 9602 234 (2.44) 1.09 (0.96–1.24) 1.05 (0.91–1.20)
Multivariable regression for number of concurrent benzodiazepine or Z-drug prescriptions
 No prescription 690,459 15,474 (2.24) Reference
 Prescription for only 1 class 84,042 2636 (3.14) 1.41 (1.35–1.47) 1.12 (1.07–1.17)
 Prescription for >1 class 10,845 375 (3.46) 1.56 (1.41–1.73) 1.24 (1.11–1.38)

ORs adjusted for age, sex, race/ethnicity, surgical procedure, comorbidities, opioid prescription, antidepressant prescription.